TAGLN
Basic information
Region (hg38): 11:117199370-117207464
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TAGLN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 13 | 15 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 9 | |||||
Total | 0 | 0 | 20 | 1 | 4 |
Variants in TAGLN
This is a list of pathogenic ClinVar variants found in the TAGLN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-117203083-G-A | not specified | Uncertain significance (Mar 02, 2023) | ||
11-117203191-G-A | not specified | Uncertain significance (Aug 08, 2023) | ||
11-117203334-T-C | not specified | Uncertain significance (Mar 24, 2023) | ||
11-117203353-C-T | not specified | Uncertain significance (Oct 11, 2024) | ||
11-117203355-G-C | Benign (Dec 11, 2017) | |||
11-117203369-G-T | not specified | Uncertain significance (Jan 04, 2024) | ||
11-117203385-G-C | not specified | Uncertain significance (Dec 15, 2022) | ||
11-117203404-A-G | not specified | Uncertain significance (Aug 17, 2021) | ||
11-117203410-C-T | not specified | Uncertain significance (May 18, 2022) | ||
11-117203847-G-T | not specified | Uncertain significance (Apr 27, 2023) | ||
11-117203848-A-T | not specified | Uncertain significance (Dec 03, 2021) | ||
11-117203888-T-C | Benign (Jun 27, 2018) | |||
11-117204287-G-T | not specified | Uncertain significance (Feb 08, 2023) | ||
11-117204292-G-A | not specified | Uncertain significance (Jul 28, 2021) | ||
11-117204298-A-G | Benign (Jul 15, 2018) | |||
11-117204303-G-C | not specified | Uncertain significance (Nov 15, 2021) | ||
11-117204316-C-A | not specified | Uncertain significance (Jan 19, 2024) | ||
11-117204332-C-T | Benign (Feb 09, 2018) | |||
11-117206001-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
11-117206025-G-A | Benign (Dec 31, 2019) | |||
11-117206067-T-G | not specified | Uncertain significance (Mar 02, 2023) | ||
11-117206071-G-C | not specified | Uncertain significance (Jul 20, 2021) | ||
11-117206158-C-T | not specified | Uncertain significance (Nov 22, 2023) | ||
11-117206221-T-G | not specified | Uncertain significance (Oct 11, 2024) | ||
11-117206229-C-T | not specified | Uncertain significance (Oct 03, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TAGLN | protein_coding | protein_coding | ENST00000532870 | 4 | 5462 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0853 | 0.876 | 125744 | 0 | 4 | 125748 | 0.0000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.367 | 112 | 123 | 0.907 | 0.00000723 | 1328 |
Missense in Polyphen | 20 | 35.082 | 0.57009 | 423 | ||
Synonymous | 0.436 | 42 | 45.8 | 0.918 | 0.00000266 | 373 |
Loss of Function | 1.76 | 3 | 8.55 | 0.351 | 3.62e-7 | 103 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Actin cross-linking/gelling protein (By similarity). Involved in calcium interactions and contractile properties of the cell that may contribute to replicative senescence. {ECO:0000250}.;
- Pathway
- PDGFR-beta signaling pathway
(Consensus)
Recessive Scores
- pRec
- 0.358
Intolerance Scores
- loftool
- 0.0465
- rvis_EVS
- -0.03
- rvis_percentile_EVS
- 51.66
Haploinsufficiency Scores
- pHI
- 0.624
- hipred
- N
- hipred_score
- 0.444
- ghis
- 0.566
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.940
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tagln
- Phenotype
- muscle phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); normal phenotype; reproductive system phenotype; growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); neoplasm;
Gene ontology
- Biological process
- muscle organ development;epithelial cell differentiation
- Cellular component
- cytoplasm
- Molecular function
- protein binding;actin filament binding